INTRODUCTION
============

There is a complex interaction between renal perfusion, renal oxygen delivery, renal oxygen consumption and glomerular filtration. Interested readers are referred to detailed reviews \[[@gfy180-B1], [@gfy180-B2]\]. The kidney is unique because \>80% of its oxygen consumption is used to power tubular sodium reabsorption. Consequently, the oxygen consumption of the kidney varies with glomerular filtration rate (GFR), and thus renal blood flow. In all other organs of the body, the direction of causation is reversed, with changes in tissue metabolic activity leading to changes in vascular tone, and thus perfusion. Another unique aspect of the renal circulation is the presence of separate cortical and medullary circulations. All blood flow to the kidney (∼25% of cardiac output at rest or ∼1200 mL/min or ∼400 mL/100 g/min in a 70 kg adult with a 300 g kidney) passes through the glomeruli of the renal cortices. The renal medullary circulation (the vasa recta) arises from the efferent arterioles of a subpopulation of glomeruli at the corticomedullary junction (the juxtamedullary glomeruli). Thus only ∼10% of renal blood flow perfuses the renal medulla, with evidence that cortical and medullary circulations are independently regulated \[[@gfy180-B3]\]. There is evolving evidence that renal tissue ischaemia and associated hypoxia are critical factors in the initiation and progression of both acute kidney injury (AKI) and chronic kidney disease (CKD), irrespective of the underlying aetiology \[[@gfy180-B4]\]. Thus to understand the physiological regulation of renal perfusion and the role of its dysregulation in kidney disease and injury, we require methods that allow quantification of renal perfusion both at the whole organ level and at the local tissue level. Traditional reference techniques for assessing renal tissue perfusion in animals and humans have significant limitations with no gold-standard technique available \[[@gfy180-B5]\]. Arterial spin labelling (ASL) is a magnetic resonance imaging (MRI) technique that uses the magnetic labelling of water in arterial blood as an endogenous tracer to quantify regional perfusion. The purpose of this review is to outline the ASL technique and summarize all human non-cancer studies performed since the technique was first described. Current gaps in knowledge are identified and recommendations for future studies are made.

MATERIALS AND METHODS
=====================

A literature search was conducted in PubMed, Ovid MEDLINE and Ovid Embase on 4 January 2018. The search strategy is outlined in detail in the [Supplementary data](#sup1){ref-type="supplementary-material"}. In brief, it comprised the terms arterial spin label, kidney, renal circulation, renal blood flow and renal perfusion. Conference abstracts, animal studies and human studies of renal cancer were excluded. Studies not published in English were excluded. Study characteristics were abstracted and cross-validated by multiple reviewers.

RESULTS
=======

Study characteristics and important MRI parameters are summarized in [Supplementary data](#sup1){ref-type="supplementary-material"}, [Table S1](#sup2){ref-type="supplementary-material"}. Studies were generally small (mean 25 ± 23 participants, range 4--98 participants) and predominantly described healthy volunteers. Hydration status was rarely reported. The time of day at which the scan was collected was described in only 7 of 53 studies, which might be pertinent due to circadian variations in renal haemodynamics. Renal cortical perfusion by ASL ranged from 139 to 427 mL/100 g/min in healthy volunteers and from 83 to 412 mL/100 g/min in a broad range of patient groups. The reproducibility of renal perfusion by ASL was reported in 17 of 53 studies. Several papers reported renal ASL perfusion values under physiological challenges. Renal ASL perfusion values were generally lower in CKD patients compared with healthy subjects and were correlated with estimated GFR (eGFR).

BASIC PRINCIPLES OF ASL
=======================

ASL uses blood water as a freely diffusible tracer to quantify renal perfusion in physiological units of mL/100 g/min. The basic ASL experiment collects two image types, referred to as the 'label' (or tag) and 'control' images. The label is applied using radiofrequency (RF) pulses to alter the longitudinal magnetization of protons in the arterial blood water before it enters the imaging plane, and an image is collected after a delay time. The control image is acquired at the same delay time without labelling the arterial blood protons. Provided that the inverted magnetization of the inflowing blood is the only difference between the control and label images, a simple subtraction of the label from the control image yields a perfusion-weighted image in which signal intensity is proportional to perfusion ([Figure 1](#gfy180-F1){ref-type="fig"}).

![Schematic showing basic principles of ASL. (**A**) Pulsed ASL (PASL) showing a single radiofrequency pulse for labelling followed by a post-label delay before the image is acquired within one TR (repetition time), with a label-control ASL pair shown. This sequence is then repeated to collect multiple ASL pairs. (**B**) Pseudocontinous ASL (pCASL) showing a train of radiofrequency pulses for labelling followed by a post-labelling delay. (**C**) Example control and label images and the resulting perfusion-weighted (PW) image created by subtraction of the label from the control image.](gfy180f1){#gfy180-F1}

The signal in each voxel of the perfusion-weighted image is entered into a kinetic model to quantify the perfusion-weighted signal and thus generate a quantitative perfusion map ([Supplementary data](#sup1){ref-type="supplementary-material"}). ASL schemes can be classified into three major groups: pulsed ASL (PASL), continuous ASL (CASL) and pseudo-continuous ASL (pCASL) schemes, with PASL and pCASL being the most widely used schemes for renal ASL. The flow-sensitive alternating inversion recovery (FAIR) variant is the PASL scheme most widely used in renal imaging ([Supplementary data](#sup1){ref-type="supplementary-material"}, [Table S1](#sup2){ref-type="supplementary-material"}). It uses an RF pulse centred on the imaging plane to invert a large volume of blood (label) and an adiabatic RF pulse to invert a spatially selective region (control). In CASL, a single long-duration RF pulse is applied to invert the arterial magnetization as blood flows through the labelling plane while a gradient is applied in the direction of arterial flow. In pCASL, a long series of short RF pulses are used to mimic the action of CASL but limit the energy deposition (specific absorption rate). pCASL is more compatible with modern MRI scanners, thus making it more feasible for clinical use ([Figure 1](#gfy180-F1){ref-type="fig"}) than original CASL implementations. In all cases, the label decays with the longitudinal relaxation time (T1) for tissue or blood, which is a variable dependent on magnetic field strength. Each label or control image is acquired after a delay time, with the image readout taking one of several schemes ([Supplementary data](#sup1){ref-type="supplementary-material"}). ASL techniques have intrinsically low signal:noise ratio, with a typical renal cortex perfusion-weighted signal intensity of 5% of the control image signal. To improve signal:noise ratio, multiple ASL control-label pairs are collected and the perfusion-weighted difference signals are averaged. Renal ASL is inherently susceptible to respiratory-induced motion of the kidney between label and control images, although averaging acts to suppress to some extent such motion-related artefacts. Limiting motion artefacts during image acquisition is a critical issue in renal ASL \[[@gfy180-B6]\]. Several alternative strategies have been employed to limit the effects of motion ([Supplementary data](#sup1){ref-type="supplementary-material"}).

VALIDATION OF RENAL ASL TO MEASURE RENAL PERFUSION
==================================================

Techniques for assessing renal tissue perfusion in animals and humans have significant limitations, with no available gold-standard technique. In animal experiments, microspheres can be used. However, due to the phenomenon of plasma skimming, these methods are inaccurate in the kidney \[[@gfy180-B5]\]. Furthermore, as microspheres are trapped in the pre-glomerular and glomerular circulations, they are unsuitable for medullary perfusion. Analyses of microsphere concentration must be done post-mortem, so this method is unsuitable for use in humans. The plasma clearance of para-aminohippurate measures effective renal blood flow in humans but is limited by its incomplete and variable renal extraction, making it a 'bronze standard' at best \[[@gfy180-B5]\]. It also provides no information about the relative perfusion of the renal cortex and medulla. Renal scintigraphy lacks spatial resolution and uses ionizing radiation, limiting repeatability. Computed tomography also uses ionizing radiation \[[@gfy180-B7]\] and requires contrast agents that can injure the kidney \[[@gfy180-B8]\]. Dynamic gadolinium contrast-enhanced MRI can measure renal perfusion, but this method is not well validated and its use is restricted in CKD due to protocols to minimize the risk of nephrogenic systemic fibrosis \[[@gfy180-B9]\].

The lack of a gold-standard technique for renal perfusion means that studies that validate renal ASL against reference techniques must be cautiously interpreted. Renal cortical perfusion measured by PASL-FAIR was compared with blood flow measured by ultrasound flowmetry in a single isolated *ex vivo* swine kidney, with the greatest observed difference of 13% \[[@gfy180-B10]\]. Artz *et al.* \[[@gfy180-B11]\] compared renal perfusion acquired with a PASL-FAIR technique at 1.5 T in 11 swines. Both ASL and microspheres showed an increase in perfusion during an acetylcholine challenge and a decrease during administration of isoflurane. The two perfusion techniques showed a good correlation (*r* = 0.81, P \< 0.0001) with a linear relationship in the physiologic range (microsphere perfusion \<550 mL/min/100 g), but perfusion values measured by ASL were systematically lower than those measured by microspheres. This may have been due in part to assumptions around the kinetic model used to determine the ASL perfusion values, but may also reflect the poor reproducibility and accuracy of the microsphere technique itself.

Ritt *et al.* \[[@gfy180-B12]\] measured perfusion by both renal ASL and para-aminohippurate clearance in 24 patients with metabolic syndrome and a Cockroft and Gault estimated creatinine clearance ≥60 mL/min. Renal perfusion by the two techniques correlated modestly (*r* = 0.575, P \< 0.001). After the patients had 2 weeks of therapy with telmisartan, an 11% increase of renal plasma flow by para-aminohippurate clearance was associated with a 6% increase by PASL-FAIR. Shimizu *et al.* \[[@gfy180-B13]\] described a modest correlation between cortical renal perfusion by a pCASL technique and 99mTc-MAG3 scintigraphy in 14 healthy volunteers. There is conflicting evidence with respect to the similarity of perfusion estimates by dynamic gadolinium contrast-enhanced MRI and ASL \[[@gfy180-B14]\]. This is expected given the differences in the tracer kinetic properties of magnetically labelled water and gadolinium contrast agents.

REPRODUCIBILITY OF RENAL ASL
============================

Renal perfusion measurements by ASL are influenced by several patient-specific and technical factors, as discussed in the [Supplementary data](#sup1){ref-type="supplementary-material"}. Comparisons of reproducibility measures are also constrained by the disparate ways in which perfusion and reproducibility values are presented. Within-subject reproducibility of perfusion by renal ASL in 17 studies is summarized in [Table 1](#gfy180-T1){ref-type="table"}. The range of study participants include healthy volunteers, hypertensives \[[@gfy180-B25]\], patients with lupus nephritis \[[@gfy180-B29]\], and kidney transplant recipients \[[@gfy180-B17], [@gfy180-B28]\]. Overall, cortical perfusion had moderate to good short-term reproducibility in the same visit \[intraclass correlation (ICC) 0.62--0.98; coefficient of variation (CV) 3--18%\] and between different visits (ICC 0.85--0.97; CV 4--13%). Ensuring reproducibility of medullary perfusion measurements provides additional challenges. These include reduced contrast:noise ratio due to lower perfusion, renal medullary volumes prone to errors in accurate segmentation and signal loss from the longer transit time of the magnetically labelled bolus as it initially passes through the cortex. Therefore it is not surprising that medullary perfusion is reported as less reproducible both within visits (ICC 0.27--0.94; CV 3--43%) and between visits (ICC 0.13--0.96; 4--37%). Studies in which both intra- and intervisit reproducibility were measured suggest that intervisit reproducibility is greater \[[@gfy180-B17], [@gfy180-B22], [@gfy180-B26]\]. At the time of this review, there are no published studies comparing the reproducibility of ASL at different magnetic field strengths or under different labelling approaches. Similarly, we found no studies of reproducibility between centres. Table 1.Reproducibility of renal perfusion by ASLReferencesParticipants, *n*B0 (T)IntravisitIntervisitICCCV (%)ICCCV (%)**Interval (days)**[^a^](#tblfn1){ref-type="table-fn"}Artz *et al.* \[[@gfy180-B17]\]10 (HV) + 14 (P)1.50.96--0.98 (C)0.72--0.78 (M)4.8--6.0 (C) 16.7--26.7 (M)0.89--0.94 (C) 0.13--0.63 (M)7.6--13.1 (C)19.8--37.0 (M)74 ± 83 (HV)19 ± 21 (P)Chowdhury *et al.* \[[@gfy180-B18]\]12 (HV)1.53.3 (C)Chowdhury *et al.* \[[@gfy180-B19]\]12 (HV)1.53.3 (C)Cox *et al.* \[[@gfy180-B20]\]11 (HV)1.5/30.80 (C)0.61 (W)9.3 ± 4.4 (C)14.9 ± 3.8 (W)NRCutajar *et al.* \[[@gfy180-B21]\]5 (HV)1.57.1--7.5 (C)5.4--5.9 (W)21 (8--174)[^a^](#tblfn1){ref-type="table-fn"}Cutajar *et al.* \[[@gfy180-B14]\]16 (HV)1.514--18 (W)7 (7--56)[^a^](#tblfn1){ref-type="table-fn"}Gardener and Francis \[[@gfy180-B22]\]4 (HV)1.510--20 (C)NRGetzin *et al.* \[[@gfy180-B23]\]15 (HV)1.50.77 (C)0.83 (M)6.7 (C) 10 (M)Gillis *et al.* \[[@gfy180-B24]\]12 (HV)30.85 (C)0.86 (W)9.2 (C)7.1 (W)4--28Hammon *et al.* \[[@gfy180-B25]\]5 (HV)+ 9 (P)1.50.95--0.96 (C)0.92--0.94 (M)0.93--0.97 (W)3.0--3.8 ± 1.2--1.7 (C)3.3--3.9 ± 1.8--2.1 (M)2.3--3.2 ± 1.0--1.5 (W)0.97 (C)0.96 (M)0.97 (W)4.2 ± 1.3 (C)4.1 ± 1.4 (M)3.4 ± 0.9 (W)14Karger *et al.* \[[@gfy180-B26]\]3 (HV)1.54.1 (W)28Kim *et al.* \[[@gfy180-B27]\]25 (HV)30.90 (C)0.42 (M)17.6 (C)42.9 (M)Lanzman *et al.* \[[@gfy180-B28]\]3 (P)1.54.1 (C)\<35Rapacchi *et al.* \[[@gfy180-B29]\]10 (HV) + 10(P)1.50.62--0.66 (C)0.46--0.47 (M)10.9--11.6 (C)20.8--21.1 (M)Robson *et al.* \[[@gfy180-B30]\]4 (HV1.51.7--8 (W)7--23 (W)7Robson *et al.* \[[@gfy180-B31]\]4 (HV)1.58.8 (W)Wu *et al.* \[[@gfy180-B16]\]4 (HV)37.9 (C)7.2 (M)[^1][^2]

RENAL ASL IN HEALTHY VOLUNTEERS
===============================

This review has highlighted several caveats in terms of both the ASL acquisition and perfusion quantification methods ([Supplementary data](#sup1){ref-type="supplementary-material"}). [Supplementary data](#sup1){ref-type="supplementary-material"}, [Table S1](#sup2){ref-type="supplementary-material"} shows the range of reported renal cortical perfusion values ranging from (139--427 mL/100 g/min) in healthy volunteers. Authors described renal perfusion by ASL under physiological challenges including water loading \[[@gfy180-B33]\], intravenous saline \[[@gfy180-B19], [@gfy180-B20]\] and injections of furosemide \[[@gfy180-B34]\]. Reduced renal perfusion with age was found in two recent studies \[[@gfy180-B13], [@gfy180-B21]\].

RENAL ASL IN KIDNEY DISEASE
===========================

Renal ASL has been applied in the study of CKD \[[@gfy180-B18], [@gfy180-B21], [@gfy180-B33], [@gfy180-B35]\], AKI \[[@gfy180-B42]\], lupus nephritis \[[@gfy180-B30], [@gfy180-B43]\], metabolic syndrome \[[@gfy180-B12]\], diabetes \[[@gfy180-B39], [@gfy180-B44]\], hypertension \[[@gfy180-B45], [@gfy180-B46]\], heart failure \[[@gfy180-B36]\] and renovascular disease \[[@gfy180-B38]\]. Consistent findings from these studies are that renal cortical perfusion is reduced in CKD compared with healthy volunteers; renal perfusion reduces with increasing stage of CKD and correlates to eGFR ([Table 2](#gfy180-T2){ref-type="table"}). Table 2.Significant correlations of renal perfusion by ASL with eGFRReferenceSettingeGFR method*r*-valueBreidthardt-2015 \[[@gfy180-B35]\]CKDMDRD0.52Gillis-2016 \[[@gfy180-B36]\]CKDCKD-EPI0.73Li-2017 \[[@gfy180-B32]\]CKDCKD-EPI0.67Mora-Gutierrez-2017 \[[@gfy180-B38]\]CKDMDRD0.62Artz-2011-MRI \[[@gfy180-B48]\]Healthy volunteer/TransplantMDRD0.85/0.62Heusch-2014 \[[@gfy180-B46]\]TransplantMDRD0.59Hueper-2015 \[[@gfy180-B47]\]TransplantMDRD0.64

RENAL ASL IN RENAL TRANSPLANT RECIPIENTS AND LIVING KIDNEY DONORS
=================================================================

Renal ASL has been applied in kidney transplant studies. Prominent findings include that renal cortical ASL perfusion values differ between patients with early and delayed graft function and correlate with allograft function \[[@gfy180-B29], [@gfy180-B47]\]. In a group of 98 transplant recipients, perfusion by PASL-FAIR reduced with increasing stage of CKD \[[@gfy180-B47]\]. Cutajar *et al.* \[[@gfy180-B51]\] showed that renal ASL can be used to determine filtration fraction and could potentially act as a biomarker of renal functional reserve in potential living kidney donors.

LONGITUDINAL AND MULTIPARAMETRIC STUDIES
========================================

The non-invasive, short-lived nature of the tracer and rapid acquisition time make renal ASL inherently suited to repeated studies over a range of timescales. These allow repeated measures experiments that would not be possible with any other perfusion technique in humans and may provide novel insights into drug mechanisms and renal pathophysiology. Examples of longitudinal studies include two randomized double-blinded crossover studies by Chowdhury *et al.* \[[@gfy180-B19], [@gfy180-B20]\]. Distinct effects of commonly used intravenous fluids on renal perfusion were found by performing ASL six times over 2 h after an infusion of one intravenous fluid then repeating the experiment on a second day for a different intravenous fluid. Niles *et al.* \[[@gfy180-B50]\] performed serial ASL imaging in 15 matched pairs of living kidney donors and recipients four times over 2 years. Significant differences were found in the 2-year profiles of cortical perfusion between the remaining kidney of donors compared with the transplanted kidney. Furthermore, a potential long-term protective effect of losartan on perfusion was seen between transplant recipients. The ability of renal ASL to track the fate of perfusion in the transplanted and remaining kidney elegantly demonstrates the potential of the technique. Longitudinal studies using renal ASL have also been described in the setting of renin--angiotensin system blockade \[[@gfy180-B12], [@gfy180-B24], [@gfy180-B46]\], hyperglycaemia \[[@gfy180-B44]\], renal denervation \[[@gfy180-B45]\] and extracorporeal lithotripsy \[[@gfy180-B53]\].

RECOMMENDATIONS AND CONCLUSION
==============================

Renal ASL is a powerful tool for non-invasive measurement of regional renal perfusion in humans, with a typical in plane resolution of 2--3 mm. Renal perfusion lacks a gold standard but the ASL technique has been validated against microspheres in animals and para-aminohippurate clearance in humans. Renal ASL yielded reproducible measurements of renal cortical and medullary perfusion in the studies that have been performed to date. Reproducibility is poorer in the medulla than the cortex, as expected. Renal ASL is highly suited to repeated measurements and longitudinal studies demonstrating the potential prognostic ability of renal ASL are anticipated. The technique shows great promise as part of multiparametric studies of renal structure and function that might inform drug development and be clinically informative. At the time of this review, there are insufficient data comparing several renal ASL variants to make definitive recommendations on the best practice for ASL data acquisition in terms of the optimal ASL labelling scheme, image readout strategy and motion compensation method. Furthermore, there is conflicting evidence and no direct comparisons to resolve whether background suppression improves ASL quantification. Multidelay acquisitions to model arterial transit time cannot be currently universally recommended as these are more technically challenging; however, they should be considered where desired. The most historically popular technique is a pulsed ASL scheme with a single-slice balanced steady-state free precession readout and motion correction. However, there are well-supported rationales for more recently described alternative approaches that suit whole kidney perfusion measurements. There is also variation in how ASL images are analysed to quantify perfusion values in terms of assumptions in the kinetic model and how renal cortex and medulla regions are defined. The lack of a harmonized approach to image acquisition, analysis and reporting might hinder progress in the clinical validation and use of the technique. Thus we have made some recommendations in Table [3](#gfy180-T3){ref-type="table"}. It is important to emphasize that in longitudinal studies the precise way in which ASL is applied is likely to matter less than ensuring consistency of experimental conditions for repeated measures to maintain reproducibility. The priority areas in which more studies are urgently needed include animal studies to validate ASL against reference renal perfusion techniques such as transit time ultrasound flowmetry; human longitudinal multiparametric MRI studies that combine ASL perfusion with other MRI measures outlined in this issue \[[@gfy180-B53]\]; clinical studies that use measured rather than eGFR and studies that validate renal perfusion against a clinical outcome, such as a change in GFR, fibrosis or graft survival. In conclusion, renal ASL is almost ready for clinical use. Collaborative projects such as the COST action PARENCHIMA will accelerate clinical validation of renal ASL as part of a multiparametric assessment of renal perfusion, oxygenation, oedema and fibrosis. Table 3.Minimum recommendations for reporting renal ASL studiesOutline patient preparation (e.g. hydration)Outline subject characteristicsMeasure systemic haemodynamics ( e.g. blood pressure)Report current medications (especially those targeting the renin--  angio-tensin system)Outline the labelling schemeReport the duration of the post-label delayOutline the readout schemeExplicitly outline how motion compensation was handledExplicitly state whether background suppression was appliedAcquire a T1 map to use in the kinetic modelDescribe how the region of interest for ASL analysis is selectedReport cortical and medullary values separatelyReport within-subject reproducibility for your site preferably both  within and between visitsMeasure other renal MRI parameters if possible (e.g. BOLD, diffusion)

SUPPLEMENTARY DATA
==================

[Supplementary data](#sup1){ref-type="supplementary-material"} are available at ndt online.
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[^1]: Values are mean* *±* *SD or median (range).

[^2]: B0, magnetic field strength (Tesla); C, cortex; CV, coefficient of variation; HV, healthy volunteers; M, medulla; NR, not reported; P, patients; W, whole kidney.
